Pituitary Adenylate-Cyclase-Activating Polypeptide (PACAP) Binding Sites and PACAP/Vasoactive Intestinal Polypeptide Receptor Expression in Human Pituitary Adenomas

This publication has 47 references indexed in Scilit:

• Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
  Journal of Clinical Investigation, 1998
• Mechanism of Action of Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) in Human Nonfunctioning Pituitary Tumors
  Journal of Neuroendocrinology, 1995
• In Situ Hybridization Analysis of Chromogranin A and B mRNAs in Neuroendocrine Tumors with Digoxigenin-Labeled Oligonucleotide Probe Cocktails
  Diagnostic Molecular Pathology, 1995
• Multiple receptors for PACAP and VIP
  Trends in Pharmacological Sciences, 1994
• Molecular Cloning and Functional Expression of a cDNA Encoding a Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor
  Biochemical and Biophysical Research Communications, 1993
• The VIP₂ receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
  FEBS Letters, 1993
• Type I receptors for PACAP (a neuropeptide even more important than VIP?)
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
• Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)
  Biochemical and Biophysical Research Communications, 1990
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
  Biochemical and Biophysical Research Communications, 1989
• The influence of vasoactive intestinal polypeptide and cholecystokinin of prolactin release in rat and human monolayer cultures
  Life Sciences, 1981